Effects of VX-407 on the Pharmacokinetics of Oral Contraceptives in Healthy Participants

Clinical trial NCT07074327 · COMPLETED

Trial details

NCT number: NCT07074327
Sponsor: Vertex Pharmaceuticals Incorporated
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Start date: 2025-07-11
Primary completion: 2026-02-20
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.